Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥2.66T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥581.5bn2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥178.4bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥593.5bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥174.7bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥442.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥124.1bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥444.2bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥124.6bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥6.35Tat 2023-03-31Cons.Assets IFRS
Total assets¥6.55Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.75Tat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.76Tat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥2.93Tat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.98Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥2.89Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.54Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥655.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥721.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥483.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.0bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥101.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥22.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥306.2bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥116.8bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥249.452022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥69.942022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥249.362022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥69.912022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.1%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-03-31¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-03-31¥611m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.8bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥0
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥318m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2022-01-01 → 2022-03-31¥524.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2022-01-01 → 2022-03-31¥523.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥59m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥181.3bn
—segment totalrevenue2022-01-01 → 2022-03-31¥581.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥580.9bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥59m
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥186.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 843
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人トーマツ
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)丸地 肖幸
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)石川 航史
Cpa3 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)松下 陽一
Number of submissionFilingDateInstant1
Revenue IFRS (5-year summary)Prior1YTDDuration581505000000JPY
Revenue IFRS (5-year summary)CurrentYTDDuration665278000000JPY
Revenue IFRS (5-year summary)Prior1YearDuration2657832000000JPY
Profit loss before tax IFRS (5-year summary)Prior1YTDDuration174699000000JPY
Profit loss before tax IFRS (5-year summary)CurrentYTDDuration183146000000JPY
Profit loss before tax IFRS (5-year summary)Prior1YearDuration593450000000JPY
Profit loss IFRS (5-year summary)Prior1YTDDuration124602000000JPY
Profit loss IFRS (5-year summary)CurrentYTDDuration145226000000JPY
Profit loss IFRS (5-year summary)Prior1YearDuration444174000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration124110000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration144684000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YearDuration442716000000JPY
Comprehensive income IFRS (5-year summary)Prior1YTDDuration230570000000JPY
Comprehensive income IFRS (5-year summary)CurrentYTDDuration170311000000JPY
Comprehensive income IFRS (5-year summary)Prior1YearDuration998229000000JPY
Total equity IFRS (5-year summary)Prior1QuarterInstant2983147000000JPY
Total equity IFRS (5-year summary)CurrentQuarterInstant3586249000000JPY
Total equity IFRS (5-year summary)Prior1YearInstant3616761000000JPY
Total assets IFRS (5-year summary)Prior1QuarterInstant5747354000000JPY
Total assets IFRS (5-year summary)CurrentQuarterInstant6346628000000JPY
Total assets IFRS (5-year summary)Prior1YearInstant6548078000000JPY
Basic earnings loss per share IFRS (5-year summary)Prior1YTDDuration69.94
Basic earnings loss per share IFRS (5-year summary)CurrentYTDDuration81.52
Basic earnings loss per share IFRS (5-year summary)Prior1YearDuration249.45
Diluted earnings loss per share IFRS (5-year summary)Prior1YTDDuration69.91
Diluted earnings loss per share IFRS (5-year summary)CurrentYTDDuration81.49
Diluted earnings loss per share IFRS (5-year summary)Prior1YearDuration249.36
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1QuarterInstant0.5056
Ratio of owners equity to gross assets IFRS (5-year summary)CurrentQuarterInstant0.5526
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1YearInstant0.5407
Cash flows from used in operating activities IFRS (5-year summary)Prior1YTDDuration38983000000JPY
Cash flows from used in operating activities IFRS (5-year summary)CurrentYTDDuration55663000000JPY
Cash flows from used in operating activities IFRS (5-year summary)Prior1YearDuration483799000000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YTDDuration-22726000000JPY
Cash flows from used in investing activities IFRS (5-year summary)CurrentYTDDuration-41707000000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YearDuration-101822000000JPY
Cash flows from used in financing activities IFRS (5-year summary)Prior1YTDDuration-116767000000JPY
Cash flows from used in financing activities IFRS (5-year summary)CurrentYTDDuration-196398000000JPY
Cash flows from used in financing activities IFRS (5-year summary)Prior1YearDuration-306176000000JPY
Cash and cash equivalents IFRS (5-year summary)Prior1QuarterInstant655260000000JPY
Cash and cash equivalents IFRS (5-year summary)CurrentQuarterInstant665152000000JPY
Cash and cash equivalents IFRS (5-year summary)Prior1YearInstant866885000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember2000000000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember2000000000

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass